Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 14;20(2):17.
doi: 10.1007/s11906-018-0798-6.

Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis

Affiliations
Review

Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis

Fernando Pedro de Souza-Neto et al. Curr Hypertens Rep. .

Abstract

Purpose of review: The purpose of this review was to summarize the current knowledge on the role of angiotensin-(1-7) [Ang-(1-7)] and alamandine in experimental hypertension and atherosclerosis.

Recent findings: The renin-angiotensin system (RAS) is a very complex system, composed of a cascade of enzymes, peptides, and receptors, known to be involved in the pathogenesis of hypertension and atherosclerosis. Ang-(1-7), identified and characterized in 1987, and alamandine, discovered 16 years after, are the newest two main effector molecules from the RAS, protecting the vascular system against hypertension and atherosclerosis. While the beneficial effects of Ang-(1-7) have been widely studied in several experimental models of hypertension, much less studies were performed in experimental models of atherosclerosis. Alamandine has shown similar vascular effects to Ang-(1-7), namely, endothelial-dependent vasorelaxation mediated by nitric oxide and hypotensive effects in experimental hypertension. There are few studies on the effects of alamandine on atherosclerosis.

Keywords: Alamandine; Angiotensin-(1–7); Atherosclerosis; Mas receptor; MrgD receptor; hypertension; Renin-angiotensin system.

PubMed Disclaimer

References

    1. Microcirculation. 2010 Apr;17(3):192-205 - PubMed
    1. J Med Invest. 2010 Feb;57(1-2):12-25 - PubMed
    1. World J Biol Chem. 2015 Aug 26;6(3):209-17 - PubMed
    1. Hypertension. 2010 Apr;55(4):889-96 - PubMed
    1. Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1270-6 - PubMed

LinkOut - more resources